Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cells in whole blood in suspension; this makes plasma the extracellular matrix of blood cells.
Highlights
The global Platelet and Plasma market was valued at US$ 5062.5 million in 2022 and is anticipated to reach US$ 5836.7 million by 2029, witnessing a CAGR of 2.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Platelets have no cell nucleus: they are fragments of cytoplasm that are derived from the megakaryocytes of the bone marrow, and then enter the circulation. Circulating unactivated platelets are biconvex discoid (lens-shaped) structures,2鈥�3 碌m in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells. Plasma makes up about 55% of the body's total blood volume.It is the intravascular fluid part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains dissolved proteins (6鈥�8%) (i.e.鈥攕erum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3鈭�, Cl鈭�, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation) and oxygen. Plasma also serves as the protein reserve of the human body. It plays a vital role in an intravascular osmotic effect that keeps electrolytes in balanced form and protects the body from infection and other blood disorders. Rising prevalence of chronic diseases such as haemophilia, thrombocytopenia, haemorrhage, liver diseases as well as other rare and infectious diseases will drive the global platelet and plasma market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Platelet and Plasma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet and Plasma.
The Platelet and Plasma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Platelet and Plasma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platelet and Plasma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
America鈥檚 Blood Centers
American Red Cross
American Association of Blood Banks
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross
German Red Cross
Indian Red Cross
Italian Red Cross
Red Cross Society of China
Saudi Red Crescent Authority
South African Red Cross Society
Segment by Type
Platelet
Plasma
Segment by Application
Hosptials
Clinics
Ambulatory Surgical Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platelet and Plasma companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Platelet and Plasma 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Platelet
1.2.3 Plasma
1.3 麻豆原创 by Application
1.3.1 Global Platelet and Plasma 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Platelet and Plasma 麻豆原创 Perspective (2018-2029)
2.2 Platelet and Plasma Growth Trends by Region
2.2.1 Global Platelet and Plasma 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Platelet and Plasma Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Platelet and Plasma Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Platelet and Plasma 麻豆原创 Dynamics
2.3.1 Platelet and Plasma Industry Trends
2.3.2 Platelet and Plasma 麻豆原创 Drivers
2.3.3 Platelet and Plasma 麻豆原创 Challenges
2.3.4 Platelet and Plasma 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet and Plasma Players by Revenue
3.1.1 Global Top Platelet and Plasma Players by Revenue (2018-2023)
3.1.2 Global Platelet and Plasma Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Platelet and Plasma 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Platelet and Plasma Revenue
3.4 Global Platelet and Plasma 麻豆原创 Concentration Ratio
3.4.1 Global Platelet and Plasma 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet and Plasma Revenue in 2022
3.5 Platelet and Plasma Key Players Head office and Area Served
3.6 Key Players Platelet and Plasma Product Solution and Service
3.7 Date of Enter into Platelet and Plasma 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet and Plasma Breakdown Data by Type
4.1 Global Platelet and Plasma Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Platelet and Plasma Forecasted 麻豆原创 Size by Type (2024-2029)
5 Platelet and Plasma Breakdown Data by Application
5.1 Global Platelet and Plasma Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Platelet and Plasma Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Platelet and Plasma 麻豆原创 Size (2018-2029)
6.2 North America Platelet and Plasma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Platelet and Plasma 麻豆原创 Size by Country (2018-2023)
6.4 North America Platelet and Plasma 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Platelet and Plasma 麻豆原创 Size (2018-2029)
7.2 Europe Platelet and Plasma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Platelet and Plasma 麻豆原创 Size by Country (2018-2023)
7.4 Europe Platelet and Plasma 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Platelet and Plasma 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Platelet and Plasma 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Platelet and Plasma 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Platelet and Plasma 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Platelet and Plasma 麻豆原创 Size (2018-2029)
9.2 Latin America Platelet and Plasma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Platelet and Plasma 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Platelet and Plasma 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet and Plasma 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Platelet and Plasma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Platelet and Plasma 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Platelet and Plasma 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 America鈥檚 Blood Centers
11.1.1 America鈥檚 Blood Centers Company Detail
11.1.2 America鈥檚 Blood Centers Business Overview
11.1.3 America鈥檚 Blood Centers Platelet and Plasma Introduction
11.1.4 America鈥檚 Blood Centers Revenue in Platelet and Plasma Business (2018-2023)
11.1.5 America鈥檚 Blood Centers Recent Development
11.2 American Red Cross
11.2.1 American Red Cross Company Detail
11.2.2 American Red Cross Business Overview
11.2.3 American Red Cross Platelet and Plasma Introduction
11.2.4 American Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.2.5 American Red Cross Recent Development
11.3 American Association of Blood Banks
11.3.1 American Association of Blood Banks Company Detail
11.3.2 American Association of Blood Banks Business Overview
11.3.3 American Association of Blood Banks Platelet and Plasma Introduction
11.3.4 American Association of Blood Banks Revenue in Platelet and Plasma Business (2018-2023)
11.3.5 American Association of Blood Banks Recent Development
11.4 Blood Centers of America
11.4.1 Blood Centers of America Company Detail
11.4.2 Blood Centers of America Business Overview
11.4.3 Blood Centers of America Platelet and Plasma Introduction
11.4.4 Blood Centers of America Revenue in Platelet and Plasma Business (2018-2023)
11.4.5 Blood Centers of America Recent Development
11.5 Brazilian Red Cross
11.5.1 Brazilian Red Cross Company Detail
11.5.2 Brazilian Red Cross Business Overview
11.5.3 Brazilian Red Cross Platelet and Plasma Introduction
11.5.4 Brazilian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.5.5 Brazilian Red Cross Recent Development
11.6 Canadian Red Cross
11.6.1 Canadian Red Cross Company Detail
11.6.2 Canadian Red Cross Business Overview
11.6.3 Canadian Red Cross Platelet and Plasma Introduction
11.6.4 Canadian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.6.5 Canadian Red Cross Recent Development
11.7 European Blood Alliance
11.7.1 European Blood Alliance Company Detail
11.7.2 European Blood Alliance Business Overview
11.7.3 European Blood Alliance Platelet and Plasma Introduction
11.7.4 European Blood Alliance Revenue in Platelet and Plasma Business (2018-2023)
11.7.5 European Blood Alliance Recent Development
11.8 French Red Cross
11.8.1 French Red Cross Company Detail
11.8.2 French Red Cross Business Overview
11.8.3 French Red Cross Platelet and Plasma Introduction
11.8.4 French Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.8.5 French Red Cross Recent Development
11.9 German Red Cross
11.9.1 German Red Cross Company Detail
11.9.2 German Red Cross Business Overview
11.9.3 German Red Cross Platelet and Plasma Introduction
11.9.4 German Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.9.5 German Red Cross Recent Development
11.10 Indian Red Cross
11.10.1 Indian Red Cross Company Detail
11.10.2 Indian Red Cross Business Overview
11.10.3 Indian Red Cross Platelet and Plasma Introduction
11.10.4 Indian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.10.5 Indian Red Cross Recent Development
11.11 Italian Red Cross
11.11.1 Italian Red Cross Company Detail
11.11.2 Italian Red Cross Business Overview
11.11.3 Italian Red Cross Platelet and Plasma Introduction
11.11.4 Italian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.11.5 Italian Red Cross Recent Development
11.12 Red Cross Society of China
11.12.1 Red Cross Society of China Company Detail
11.12.2 Red Cross Society of China Business Overview
11.12.3 Red Cross Society of China Platelet and Plasma Introduction
11.12.4 Red Cross Society of China Revenue in Platelet and Plasma Business (2018-2023)
11.12.5 Red Cross Society of China Recent Development
11.13 Saudi Red Crescent Authority
11.13.1 Saudi Red Crescent Authority Company Detail
11.13.2 Saudi Red Crescent Authority Business Overview
11.13.3 Saudi Red Crescent Authority Platelet and Plasma Introduction
11.13.4 Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2018-2023)
11.13.5 Saudi Red Crescent Authority Recent Development
11.14 South African Red Cross Society
11.14.1 South African Red Cross Society Company Detail
11.14.2 South African Red Cross Society Business Overview
11.14.3 South African Red Cross Society Platelet and Plasma Introduction
11.14.4 South African Red Cross Society Revenue in Platelet and Plasma Business (2018-2023)
11.14.5 South African Red Cross Society Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
America鈥檚 Blood Centers
American Red Cross
American Association of Blood Banks
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross
German Red Cross
Indian Red Cross
Italian Red Cross
Red Cross Society of China
Saudi Red Crescent Authority
South African Red Cross Society
听
听
*If Applicable.
